Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Ferring Pharmaceuticals Ltd., Drayton Hall, Church Road, West Drayton, UB7 7PS, United Kingdom
Lutigest 100 mg vaginal tablets.
| Pharmaceutical Form |
|---|
|
Vaginal tablet. White to off-white flat and oval tablet with the inscriptions “FPI” on one side and “100” on the other side. The vaginal tablets are supplied with one polyethylene vaginal applicator. |
1 vaginal tablet contains 100 mg progesterone.
Excipient with known effect: 1 vaginal tablet contains approximately 760 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Progesterone |
Progesterone is a natural progestogen, the main hormone of the corpus luteum and the placenta. It acts on the endometrium by converting the proliferating phase to the secretory phase. |
| List of Excipients |
|---|
|
Silica, hydrophobic colloidal |
Alu/Alu blisters of 3 vaginal tablets.
The blisters are available in cartons with 21 or 90 vaginal tablets with 1 vaginal applicator.
Not all pack sizes may be marketed.
Ferring Pharmaceuticals Ltd., Drayton Hall, Church Road, West Drayton, UB7 7PS, United Kingdom
PL 03194/0103
19/11/2009
| Drug | Countries | |
|---|---|---|
| LUTIGEST | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
